Special Commentary: Cerebral/Cortical Visual Impairment Working Definition: A Report from the National Institutes of Health CVI Workshop

Cerebral/cortical visual impairment (CVI), a brain-based condition, has emerged as a leading cause of pediatric visual impairment in the United States and other industrialized nations. The National Eye Institute (NEI) recognized CVI as a priority area for research as part of their 2021 NEI Vision fo...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Ophthalmology (Rochester, Minn.) Minn.), 2024-12, Vol.131 (12), p.1359
Hauptverfasser: Chang, Melinda Y, Merabet, Lotfi B
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue 12
container_start_page 1359
container_title Ophthalmology (Rochester, Minn.)
container_volume 131
creator Chang, Melinda Y
Merabet, Lotfi B
description Cerebral/cortical visual impairment (CVI), a brain-based condition, has emerged as a leading cause of pediatric visual impairment in the United States and other industrialized nations. The National Eye Institute (NEI) recognized CVI as a priority area for research as part of their 2021 NEI Vision for the Future Strategic Plan and partnered with the Eunice Kennedy Shriver National Institute of Child Health and Human Development and the National Institute of Neurologic Disorders and Stroke within the National Institutes of Health (NIH) to sponsor a CVI Workshop in November 2023. A panel consisting of a group of clinicians with expertise in diagnosing CVI convened to draft a working definition for this condition. Five key elements were identified: (1) CVI encompasses a spectrum of visual impairments caused by an underlying brain abnormality that affects the development of visual processing pathways and is characterized by deficits in visual function and functional vision; (2) the visual dysfunction in CVI is greater than expected by any comorbid ocular conditions alone; (3) the visual dysfunction in CVI may manifest as lower-order or higher-order afferent visual deficits, or both, leading to characteristic behaviors in affected individuals; (4) although CVI may be comorbid with other neurodevelopmental disorders, CVI is not primarily a disorder of language, learning, or social communication; and (5) the underlying neurologic insult of the developing brain may go unrecognized or undiagnosed until later in life. Future work is needed to achieve consensus on nomenclature, diagnostic criteria, and strategies for early identification and intervention. The NIH is developing a CVI registry to collect relevant demographic and clinical data prospectively and longitudinally to help inform future research questions and to provide insight into considerations for future clinical trials in the field of CVI.
doi_str_mv 10.1016/j.ophtha.2024.09.017
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_proquest_miscellaneous_3131850807</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>3131850807</sourcerecordid><originalsourceid>FETCH-LOGICAL-p141t-ca0c09f903dcc9a090af124dcae5a4c652e48074fffe5bfe39cb4c449c51ceb43</originalsourceid><addsrcrecordid>eNpNkMlOwzAYhC0EoqXwBgj5yKWpHTtJ3VsVllaqQGIpx8pxfxOXJA62c-ANeGxSFonTjDTfzGEQOqckooSmk11k2zKUMopJzCMiIkKzAzSkCRdjnlF2-M8P0In3O0JImjJ-jAZMJFlM4-kQfT62oIyscG7rGpog3ccM5-CgcLKa5NYFo_p0bXzXy7JupXF7Dr9Y92aaV3wF2jQmGNvM8Bw_QNtXsHa2xqEEfCf3yb7Z-GBCF8Bjq_ECZBVKnK-X3zu-tO0pOtKy8nD2qyP0fHP9lC_Gq_vbZT5fjVvKaRgrSRQRWhC2VUpIIojUNOZbJSGRXKVJDHxKMq61hqTQwIQquOJcqIQqKDgbocuf3dbZ9w582NTGK6gq2YDt_IZRRqcJ6Td69OIX7YoatpvWmbr_Z_P3HvsCl_Z2MA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>3131850807</pqid></control><display><type>article</type><title>Special Commentary: Cerebral/Cortical Visual Impairment Working Definition: A Report from the National Institutes of Health CVI Workshop</title><source>MEDLINE</source><source>Access via ScienceDirect (Elsevier)</source><creator>Chang, Melinda Y ; Merabet, Lotfi B</creator><creatorcontrib>Chang, Melinda Y ; Merabet, Lotfi B ; CVI Working Group</creatorcontrib><description>Cerebral/cortical visual impairment (CVI), a brain-based condition, has emerged as a leading cause of pediatric visual impairment in the United States and other industrialized nations. The National Eye Institute (NEI) recognized CVI as a priority area for research as part of their 2021 NEI Vision for the Future Strategic Plan and partnered with the Eunice Kennedy Shriver National Institute of Child Health and Human Development and the National Institute of Neurologic Disorders and Stroke within the National Institutes of Health (NIH) to sponsor a CVI Workshop in November 2023. A panel consisting of a group of clinicians with expertise in diagnosing CVI convened to draft a working definition for this condition. Five key elements were identified: (1) CVI encompasses a spectrum of visual impairments caused by an underlying brain abnormality that affects the development of visual processing pathways and is characterized by deficits in visual function and functional vision; (2) the visual dysfunction in CVI is greater than expected by any comorbid ocular conditions alone; (3) the visual dysfunction in CVI may manifest as lower-order or higher-order afferent visual deficits, or both, leading to characteristic behaviors in affected individuals; (4) although CVI may be comorbid with other neurodevelopmental disorders, CVI is not primarily a disorder of language, learning, or social communication; and (5) the underlying neurologic insult of the developing brain may go unrecognized or undiagnosed until later in life. Future work is needed to achieve consensus on nomenclature, diagnostic criteria, and strategies for early identification and intervention. The NIH is developing a CVI registry to collect relevant demographic and clinical data prospectively and longitudinally to help inform future research questions and to provide insight into considerations for future clinical trials in the field of CVI.</description><identifier>ISSN: 1549-4713</identifier><identifier>EISSN: 1549-4713</identifier><identifier>DOI: 10.1016/j.ophtha.2024.09.017</identifier><identifier>PMID: 39572128</identifier><language>eng</language><publisher>United States</publisher><subject>Humans ; National Eye Institute (U.S.) ; National Institutes of Health (U.S.) ; United States ; Vision Disorders - diagnosis ; Vision Disorders - physiopathology</subject><ispartof>Ophthalmology (Rochester, Minn.), 2024-12, Vol.131 (12), p.1359</ispartof><rights>Copyright © 2024 American Academy of Ophthalmology. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/39572128$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Chang, Melinda Y</creatorcontrib><creatorcontrib>Merabet, Lotfi B</creatorcontrib><creatorcontrib>CVI Working Group</creatorcontrib><title>Special Commentary: Cerebral/Cortical Visual Impairment Working Definition: A Report from the National Institutes of Health CVI Workshop</title><title>Ophthalmology (Rochester, Minn.)</title><addtitle>Ophthalmology</addtitle><description>Cerebral/cortical visual impairment (CVI), a brain-based condition, has emerged as a leading cause of pediatric visual impairment in the United States and other industrialized nations. The National Eye Institute (NEI) recognized CVI as a priority area for research as part of their 2021 NEI Vision for the Future Strategic Plan and partnered with the Eunice Kennedy Shriver National Institute of Child Health and Human Development and the National Institute of Neurologic Disorders and Stroke within the National Institutes of Health (NIH) to sponsor a CVI Workshop in November 2023. A panel consisting of a group of clinicians with expertise in diagnosing CVI convened to draft a working definition for this condition. Five key elements were identified: (1) CVI encompasses a spectrum of visual impairments caused by an underlying brain abnormality that affects the development of visual processing pathways and is characterized by deficits in visual function and functional vision; (2) the visual dysfunction in CVI is greater than expected by any comorbid ocular conditions alone; (3) the visual dysfunction in CVI may manifest as lower-order or higher-order afferent visual deficits, or both, leading to characteristic behaviors in affected individuals; (4) although CVI may be comorbid with other neurodevelopmental disorders, CVI is not primarily a disorder of language, learning, or social communication; and (5) the underlying neurologic insult of the developing brain may go unrecognized or undiagnosed until later in life. Future work is needed to achieve consensus on nomenclature, diagnostic criteria, and strategies for early identification and intervention. The NIH is developing a CVI registry to collect relevant demographic and clinical data prospectively and longitudinally to help inform future research questions and to provide insight into considerations for future clinical trials in the field of CVI.</description><subject>Humans</subject><subject>National Eye Institute (U.S.)</subject><subject>National Institutes of Health (U.S.)</subject><subject>United States</subject><subject>Vision Disorders - diagnosis</subject><subject>Vision Disorders - physiopathology</subject><issn>1549-4713</issn><issn>1549-4713</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpNkMlOwzAYhC0EoqXwBgj5yKWpHTtJ3VsVllaqQGIpx8pxfxOXJA62c-ANeGxSFonTjDTfzGEQOqckooSmk11k2zKUMopJzCMiIkKzAzSkCRdjnlF2-M8P0In3O0JImjJ-jAZMJFlM4-kQfT62oIyscG7rGpog3ccM5-CgcLKa5NYFo_p0bXzXy7JupXF7Dr9Y92aaV3wF2jQmGNvM8Bw_QNtXsHa2xqEEfCf3yb7Z-GBCF8Bjq_ECZBVKnK-X3zu-tO0pOtKy8nD2qyP0fHP9lC_Gq_vbZT5fjVvKaRgrSRQRWhC2VUpIIojUNOZbJSGRXKVJDHxKMq61hqTQwIQquOJcqIQqKDgbocuf3dbZ9w582NTGK6gq2YDt_IZRRqcJ6Td69OIX7YoatpvWmbr_Z_P3HvsCl_Z2MA</recordid><startdate>202412</startdate><enddate>202412</enddate><creator>Chang, Melinda Y</creator><creator>Merabet, Lotfi B</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>7X8</scope></search><sort><creationdate>202412</creationdate><title>Special Commentary: Cerebral/Cortical Visual Impairment Working Definition: A Report from the National Institutes of Health CVI Workshop</title><author>Chang, Melinda Y ; Merabet, Lotfi B</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-p141t-ca0c09f903dcc9a090af124dcae5a4c652e48074fffe5bfe39cb4c449c51ceb43</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>Humans</topic><topic>National Eye Institute (U.S.)</topic><topic>National Institutes of Health (U.S.)</topic><topic>United States</topic><topic>Vision Disorders - diagnosis</topic><topic>Vision Disorders - physiopathology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Chang, Melinda Y</creatorcontrib><creatorcontrib>Merabet, Lotfi B</creatorcontrib><creatorcontrib>CVI Working Group</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>MEDLINE - Academic</collection><jtitle>Ophthalmology (Rochester, Minn.)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Chang, Melinda Y</au><au>Merabet, Lotfi B</au><aucorp>CVI Working Group</aucorp><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Special Commentary: Cerebral/Cortical Visual Impairment Working Definition: A Report from the National Institutes of Health CVI Workshop</atitle><jtitle>Ophthalmology (Rochester, Minn.)</jtitle><addtitle>Ophthalmology</addtitle><date>2024-12</date><risdate>2024</risdate><volume>131</volume><issue>12</issue><spage>1359</spage><pages>1359-</pages><issn>1549-4713</issn><eissn>1549-4713</eissn><abstract>Cerebral/cortical visual impairment (CVI), a brain-based condition, has emerged as a leading cause of pediatric visual impairment in the United States and other industrialized nations. The National Eye Institute (NEI) recognized CVI as a priority area for research as part of their 2021 NEI Vision for the Future Strategic Plan and partnered with the Eunice Kennedy Shriver National Institute of Child Health and Human Development and the National Institute of Neurologic Disorders and Stroke within the National Institutes of Health (NIH) to sponsor a CVI Workshop in November 2023. A panel consisting of a group of clinicians with expertise in diagnosing CVI convened to draft a working definition for this condition. Five key elements were identified: (1) CVI encompasses a spectrum of visual impairments caused by an underlying brain abnormality that affects the development of visual processing pathways and is characterized by deficits in visual function and functional vision; (2) the visual dysfunction in CVI is greater than expected by any comorbid ocular conditions alone; (3) the visual dysfunction in CVI may manifest as lower-order or higher-order afferent visual deficits, or both, leading to characteristic behaviors in affected individuals; (4) although CVI may be comorbid with other neurodevelopmental disorders, CVI is not primarily a disorder of language, learning, or social communication; and (5) the underlying neurologic insult of the developing brain may go unrecognized or undiagnosed until later in life. Future work is needed to achieve consensus on nomenclature, diagnostic criteria, and strategies for early identification and intervention. The NIH is developing a CVI registry to collect relevant demographic and clinical data prospectively and longitudinally to help inform future research questions and to provide insight into considerations for future clinical trials in the field of CVI.</abstract><cop>United States</cop><pmid>39572128</pmid><doi>10.1016/j.ophtha.2024.09.017</doi></addata></record>
fulltext fulltext
identifier ISSN: 1549-4713
ispartof Ophthalmology (Rochester, Minn.), 2024-12, Vol.131 (12), p.1359
issn 1549-4713
1549-4713
language eng
recordid cdi_proquest_miscellaneous_3131850807
source MEDLINE; Access via ScienceDirect (Elsevier)
subjects Humans
National Eye Institute (U.S.)
National Institutes of Health (U.S.)
United States
Vision Disorders - diagnosis
Vision Disorders - physiopathology
title Special Commentary: Cerebral/Cortical Visual Impairment Working Definition: A Report from the National Institutes of Health CVI Workshop
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-22T19%3A43%3A09IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Special%20Commentary:%20Cerebral/Cortical%20Visual%20Impairment%20Working%20Definition:%20A%20Report%20from%20the%20National%20Institutes%20of%20Health%20CVI%20Workshop&rft.jtitle=Ophthalmology%20(Rochester,%20Minn.)&rft.au=Chang,%20Melinda%20Y&rft.aucorp=CVI%20Working%20Group&rft.date=2024-12&rft.volume=131&rft.issue=12&rft.spage=1359&rft.pages=1359-&rft.issn=1549-4713&rft.eissn=1549-4713&rft_id=info:doi/10.1016/j.ophtha.2024.09.017&rft_dat=%3Cproquest_pubme%3E3131850807%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=3131850807&rft_id=info:pmid/39572128&rfr_iscdi=true